| Authors: |
Puig N; University Hospital of Salamanca, Salamanca, Spain., Leleu X; CHU Poitiers, Poitiers, France., Lee HC; University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Davies FE; NYU Langone, New York, New York, USA., Hájek R; Department of Haematooncology, University Hospital Ostrava, Ostrava, Czech Republic.; Department of Haematooncology, Faculty of Medicine, University of Ostrava, Ostrava, Czech Republic., Hungria V; Clinica Sao Germano, Sao Paulo, Brazil., Thompson MA; Tempus AI, Chicago, Illinois, USA., Cook G; University of Leeds, Leeds, UK., Ojeda JV; Escuela Nacional de Ciencias Biologicas, Instituto Politecnico Nacional, Mexico City, Mexico., Weisel KC; Universitaetsklinikum Hamburg-Eppendorf, Hamburg, Germany., Berdeja JG; Tennessee Oncology, Nashville, Tennessee, USA., Usmani SZ; Memorial Sloan Kettering Cancer Center, New York, New York, USA., Symeonidis A; University of Patras Medical School & Olympion Hospital, Patras, Greece., Nascimento-Ferreira I; Takeda Pharmaceuticals International AG, Opfikon, Switzerland., Arthur D; Takeda Development Center Americas, Inc. (TDCA), Cambridge, Massachusetts, USA., Mokrá L; Institut biostatistiky a analýz, s.r.o., Brno, Czech Republic., Ren K; Takeda Development Center Americas, Inc. (TDCA), Cambridge, Massachusetts, USA., Cherepanov D; Takeda Development Center Americas, Inc. (TDCA), Cambridge, Massachusetts, USA., Terpos E; National and Kapodistrian University of Athens, School of Medicine, Athens, Greece. |
